Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johan Dixelius

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Cancer Letters|July 16, 2003
Endostatin action and intracellular signaling: beta-catenin as a potential target?Johan Dixelius, Michael J Cross, Taro Matsumoto, et al.
Trends in Biochemical Sciences|September 19, 2003
VEGF-receptor signal transductionMichael J Cross, Johan Dixelius, Taro Matsumoto, et al.
FEBS Letters|February 15, 2003
Angiostatin and endostatin inhibit endothelial cell migration in response to FGF and VEGF without interfering with specific intracellular signal transduction pathwaysKerstin Eriksson, Peetra Magnusson, Johan Dixelius, et al.
Cancer Research|April 4, 2002
Endostatin regulates endothelial cell adhesion and cytoskeletal organizationJohan Dixelius, Michael Cross, Taro Matsumoto, et al.
The Journal of Biological Chemistry|March 27, 2004
Laminin-1 promotes angiogenesis in synergy with fibroblast growth factor by distinct regulation of the gene and protein expression profile in endothelial cellsJohan Dixelius, Lars Jakobsson, Elke Genersch, et al.
Experimental Cell Research|June 14, 2006
Signal transduction in endothelial cells by the angiogenesis inhibitor histidine-rich glycoprotein targets focal adhesionsChunsik Lee, Johan Dixelius, Asa Thulin, et al.
Cancer Research|February 21, 2006
Minimal active domain and mechanism of action of the angiogenesis inhibitor histidine-rich glycoproteinJohan Dixelius, Anna-Karin Olsson, Asa Thulin, et al.
The Journal of Biological Chemistry|July 26, 2003
Ligand-induced vascular endothelial growth factor receptor-3 (VEGFR-3) heterodimerization with VEGFR-2 in primary lymphatic endothelial cells regulates tyrosine phosphorylation sitesJohan Dixelius, Taija Makinen, Maria Wirzenius, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2006
Identification of proangiogenic genes and pathways by high-throughput functional genomics: TBK1 and the IRF3 pathwayChristian Korherr, Hendrik Gille, Rolf Schäfer, et al.
Cancer Research|January 28, 2004
A fragment of histidine-rich glycoprotein is a potent inhibitor of tumor vascularizationAnna-Karin Olsson, Helena Larsson, Johan Dixelius, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Cancer Letters|July 16, 2003
Endostatin action and intracellular signaling: beta-catenin as a potential target?Johan Dixelius, Michael J Cross, Taro Matsumoto, et al.
Trends in Biochemical Sciences|September 19, 2003
VEGF-receptor signal transductionMichael J Cross, Johan Dixelius, Taro Matsumoto, et al.
FEBS Letters|February 15, 2003
Angiostatin and endostatin inhibit endothelial cell migration in response to FGF and VEGF without interfering with specific intracellular signal transduction pathwaysKerstin Eriksson, Peetra Magnusson, Johan Dixelius, et al.
Cancer Research|April 4, 2002
Endostatin regulates endothelial cell adhesion and cytoskeletal organizationJohan Dixelius, Michael Cross, Taro Matsumoto, et al.
The Journal of Biological Chemistry|March 27, 2004
Laminin-1 promotes angiogenesis in synergy with fibroblast growth factor by distinct regulation of the gene and protein expression profile in endothelial cellsJohan Dixelius, Lars Jakobsson, Elke Genersch, et al.
Experimental Cell Research|June 14, 2006
Signal transduction in endothelial cells by the angiogenesis inhibitor histidine-rich glycoprotein targets focal adhesionsChunsik Lee, Johan Dixelius, Asa Thulin, et al.
Cancer Research|February 21, 2006
Minimal active domain and mechanism of action of the angiogenesis inhibitor histidine-rich glycoproteinJohan Dixelius, Anna-Karin Olsson, Asa Thulin, et al.
The Journal of Biological Chemistry|July 26, 2003
Ligand-induced vascular endothelial growth factor receptor-3 (VEGFR-3) heterodimerization with VEGFR-2 in primary lymphatic endothelial cells regulates tyrosine phosphorylation sitesJohan Dixelius, Taija Makinen, Maria Wirzenius, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2006
Identification of proangiogenic genes and pathways by high-throughput functional genomics: TBK1 and the IRF3 pathwayChristian Korherr, Hendrik Gille, Rolf Schäfer, et al.
Cancer Research|January 28, 2004
A fragment of histidine-rich glycoprotein is a potent inhibitor of tumor vascularizationAnna-Karin Olsson, Helena Larsson, Johan Dixelius, et al.
Pageof 2